Antibacterial bismuth complexes

US10501487B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10501487-B2
Application numberUS-201615576531-A
CountryUS
Kind codeB2
Filing dateMay 26, 2016
Priority dateMay 26, 2015
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are organobismuth (III) phosphinate complexes, which comprise a phosphinate group and an aromatic carbocyclyl or aromatic heterocyclyl group. The complexes find use as antibacterial agents, and accordingly also provided herein are products, devices, compositions and materials comprising the complexes, for example medical products such as wound dressings and bandages.

First claim

Opening claim text (preview).

The invention claimed is: 1. An organobismuth (III) phosphinate complex having a structure comprising formula (a): wherein R 1 is a phosphinate group; R 2 is an aromatic carbocyclyl or aromatic heterocyclyl group; and R 3 is a phosphinate group, an aromatic carbocyclyl or aromatic heterocyclyl group, or a ligand; and wherein the complex is not 2. The complex of claim 1 , wherein R 3 is a phosphinate group, or an aromatic carbocyclyl or aromatic heterocyclyl group. 3. The complex of claim 2 , wherein R 3 is a phosphinate group. 4. The complex of claim 1 , wherein the phosphinate group has the formula (b) and each R a is independently selected from the group consisting of hydrogen, optionally substituted C 1-10 alkyl, optionally substituted C 2-10 alkenyl, optionally substituted C 2-10 alkynyl, optionally substituted C 3-10 carbocyclyl and optionally substituted C 3-10 heterocyclyl. 5. The complex of claim 4 , wherein the complex has the formula (c) 6. The complex of claim 5 , wherein each R a is hydrogen. 7. The complex of claim 5 , wherein each R a is unsubstituted C 1-6 alkyl. 8. The complex of claim 5 , wherein each R a is C 6-10 aromatic carbocyclyl or C 6-10 aromatic heterocyclyl, said aromatic carbocyclyl or aromatic heterocyclyl being unsubstituted or substituted with up to 3 substituents selected from the group consisting of halogen, —CN, —NO 2 , —C 1-6 alkyl, —C 2-6 alkenyl, —C 2-6 alkynyl and —OC 1-6 alkyl. 9. The complex of claim 5 , wherein R a is selected from the group consisting of hydrogen, C 1-6 alkyl, C 6-10 aromatic carbocyclyl or C 5-10 aromatic heterocyclyl, said aromatic carbocyclyl or aromatic heterocyclyl being unsubstituted or substituted with up to 3 substituents selected from the group consisting of halogen, —CN, —NO 2 , —C 1-6 alkyl, —C 2-6 alkenyl, —C 2-6 alkynyl and —OC 1-6 alkyl; and R 2 is C 6-10 aromatic carbocyclyl or C 5-10 aromatic heterocyclyl, said aromatic carbocyclyl or aromatic heterocyclyl being unsubstituted or substituted with up to 3 substituents each independently selected from the group consisting of halogen, —CN, —NO 2 , C 1-6 alkyl, —C 2-6 alkenyl, —C 2-6 alkynyl and —OC 1-6 alkyl. 10. The complex of claim 1 , wherein R 2 is C 6-10 aromatic carbocyclyl or C 5-10 aromatic heterocyclyl, said aromatic carbocyclyl or aromatic heterocyclyl being unsubstituted or substituted with up to 3 substituents each independently selected from the group consisting of halogen, —CN, —NO 2 , C 1-6 alkyl, —C 2-6 alkenyl, —C 2-6 alkynyl and OC 1-6 alkyl. 11. The complex of claim 10 , wherein R 2 is phenyl which is unsubstituted or substituted with up to 3 substituents each independently selected from the group consisting of halogen, —CN, —NO 2 , C 1-6 alkyl, —C 2-6 alkenyl, —C 2-6 alkynyl and OC 1-6 alkyl. 12. The complex of claim 1 , wherein the complex is selected from the group consisting of: 13. The complex of claim 1 , wherein the complex is: 14. A product, device, material, or composition comprising a complex of claim 1 . 15. The product, device, material, or composition of claim 14 , wherein the product, device, material or composition comprises an antibacterial surface coating comprising the complex. 16. The composition of claim 14 , wherein the composition is a polymerisable and/or curable composition. 17. The product, device, material, or composition of claim 15 , wherein the product, device, material, or composition is a wound dressing, a suture, a surgical implement, or a medical implant. 18. The product, device, composition, or material of claim 14 , wherein the product, device, material, or composition is a medical adhesive, a bone cement, a dental adhesive or a dental filler composition. 19. The product, device, material, or composition of claim 14 , wherein the product, device, material, or composition is for use in building construction, renovation, and/or maintenance and wherein the product, device, material, or composition is a coating, sealant, cement, concrete, grout, mortar, or stucco composition. 20. The product, device, material, or composition of claim 14 , wherein the product, device, material, or composition comprises antibacterial packaging comprising the complex. 21. The product, device, material, or composition of claim 14 , wherein the product, device, material, or composition is a cellulosic material.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10501487B2 cover?
Provided herein are organobismuth (III) phosphinate complexes, which comprise a phosphinate group and an aromatic carbocyclyl or aromatic heterocyclyl group. The complexes find use as antibacterial agents, and accordingly also provided herein are products, devices, compositions and materials comprising the complexes, for example medical products such as wound dressings and bandages.
Who is the assignee on this patent?
Univ Monash
What technology area does this patent fall under?
Primary CPC classification C07F9/94. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).